Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines

被引：52
|
作者：
Gawad, Nagwa M. Abdel [1 ]
Amin, Noha H. [2 ]
Elsaadi, Mohammed T. [2 ]
Mohamed, Fatma M. M. [2 ]
Angeli, Andrea [3 ]
De Luca, Viviana [4 ]
Capasso, Clemente [4 ]
Supuran, Claudiu T. [3 ]
机构：
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[3] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy
[4] CNR, Ist Biosci & Biorisorse, Via Pietro Castellino 81, I-80125 Naples, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 13期
关键词：
Carbonic anhydrase; Inhibitor; Sulfonamide; Antitumor; Cytotoxic agent; RAY CRYSTAL-STRUCTURE; HUMAN ISOFORM-II; ISOZYME-II; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATIONS; SULFONAMIDE DERIVATIVES; XII INHIBITORS; BINDING; ANTICANCER; HYPOXIA;
D O I：
10.1016/j.bmc.2016.05.016
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of 4-(thiazol-2-ylamino)-benzenesulfonamides was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibitory and cytotoxic activity on human breast cancer cell line MCF-7. Human (h) CA isoforms I, II and IX were included in the study. The new sulfonamides showed excellent inhibition of all three isoforms, with K(I)s in the range of 0.84-702 nM against hCA I, of 0.41-288 nM against hCA II and of 5.6-29.2 against the tumor-associated hCA IX, a validated anti-tumor target, with a sulfonamide (SLC-0111) in Phase I clinical trials for the treatment of hypoxic, metastatic solid tumors overexpressing CA IX. The new compounds showed micromolar inhibition of growth efficacy against breast cancer MCF-7 cell lines. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3043 / 3051
页数：9
相关论文
共 50 条
  • [1] Synthesis of 4-(2-substituted hydrazinyl)benzenesulfonamides and their carbonic anhydrase inhibitory effects
    Gul, Halise Inci
    Kucukoglu, Kaan
    Yamali, Cem
    Bilginer, Sinan
    Yuca, Hafize
    Ozturk, Iknur
    Taslimi, Parham
    Gulcin, Ilhami
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (04) : 568 - 573
  • [2] Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII
    Durgun, Mustafa
    Turkmen, Hasan
    Ceruso, Mariangela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (11) : 2377 - 2381
  • [3] Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII
    Durgun, Mustafa
    Turkmen, Hasan
    Ceruso, Mariangela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (05) : 982 - 988
  • [4] Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl) benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity
    Suthar, Sharad Kumar
    Bansal, Sumit
    Lohan, Sandeep
    Modak, Vikarm
    Chaudhary, Anil
    Tiwari, Amit
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 66 : 372 - 379
  • [5] Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines
    Angeli, Andrea
    Trallori, Elena
    Carta, Fabrizio
    Mannelli, Lorenzo Di Cesare
    Ghelardini, Carla
    Supuran, Claudiu T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (09): : 947 - 951
  • [6] Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines
    Winum, Jean-Yves
    Carta, Fabrizio
    Ward, Carol
    Mullen, Peter
    Harrison, David
    Langdon, Simon P.
    Cecchi, Alessandro
    Scozzafava, Andrea
    Kunkler, Ian
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4681 - 4685
  • [7] Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII
    Esirden, Ibrahim
    Ulus, Ramazan
    Aday, Burak
    Tanc, Muhammet
    Supuran, Claudiu T.
    Kaya, Muharrem
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (20) : 6573 - 6580
  • [8] Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties
    Ghorab, Mostafa M.
    Alsaid, Mansour S.
    Ceruso, Mariangela
    Nissan, Yassin M.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (14) : 3684 - 3695
  • [9] Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines
    Morsy, Salwa M. I.
    Badawi, Abdelfattah M.
    Cecchi, Alessandro
    Scozzafava, Andrea
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (02) : 499 - 505
  • [10] Synthesis of a new series of N4-substituted 4-(2-aminoethyl) benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII
    Slawinski, Jaroslaw
    Brzozowski, Zdzislaw
    Zolnowska, Beata
    Szafranski, Krzysztof
    Pogorzelska, Aneta
    Vullo, Daniela
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 84 : 59 - 67
12345